Ann: Results from Data Confirmation Study, page-125

Pfizer is going nowhere. It is committed to the deal. So I'm holding and will let them have the shares at 14.6 if the vote gets up.

The nervous nellies selling now are just scrambling to retain some money because they bought higher.

The deal for Pfizer is still a good one. The IP is worth what they are paying and the cough data is now even more unique because all of the baseline data is pre covid and untainted. Having pre covid data is a game changer because how hard is it to now collect pre covid data....its impossible.